Harvard Business Review : fornisce un elenco dei CEO più influenti

- rockefeller-university
- harvard-medical-school
- stanford-university
- business-roundtable
- us-china-business-council
- general-atlantic
- PepsiCo

CIA:
[v] In-Q-Tel : CIA venture capital
- Christopher Darby
- Gilman Louie
- Keyhole (Google Earth precursore)


VISA

  Persone create:
  - [v] ryan-mcinerney - CEO Visa dal 2023, ex JPMorgan/McKinsey
  - [v] john-lundgren - Chairman Visa dal 2024, ex CEO Stanley Black & Decker
  - [v] alfred-kelly - ex CEO/Chairman Visa 2016-2024
  - [v] ramon-laguarta - CEO PepsiCo, board Visa

  Stub organizzazioni:
  - stanley-black-decker (Company)
  - mckinsey esisteva gia', aggiornato

  Relazioni create:
  - Ryan McInerney → Visa (executive), JPMorgan Chase (executive), McKinsey (partner)
  - John Lundgren → Visa (chairman), Stanley Black & Decker (executive)
  - Alfred Kelly → Visa (executive, 2016-2024)
  - Ramon Laguarta → Visa (board), PepsiCo (executive)
  - Charlotte Hogg → Visa (executive, 2017-2025) - esistente

MASTERCARD

  Persone create/aggiornate

  | Persona            | Nazionalità | Ruoli                                                     |
  |--------------------|-------------|-----------------------------------------------------------|
  | [v] Michael Miebach    | DEU         | Mastercard CEO, IBM board, WEF IBC, Business Roundtable   |
  | Merit Janow        | USA         | Mastercard Board Chair                                    |
  | [v] Julius Genachowski | USA         | Mastercard board, Carlyle Senior Advisor, ex-FCC Chairman |
  | Richard Davis      | USA         | Mastercard board, ex-CEO US Bancorp                       |

  Relazioni create

  AFFILIATED_WITH:
  - Miebach → Mastercard (executive, CEO 2021-)
  - Miebach → IBM (board, 2023-)
  - Miebach → WEF (member, IBC)
  - Miebach → Business Roundtable (member)
  - Merit Janow → Mastercard (chairman)
  - Julius Genachowski → Mastercard (board)
  - Julius Genachowski → Carlyle Group (advisor)
  - Julius Genachowski → Governo USA (executive, FCC Chairman 2009-13)
  - Richard Davis → Mastercard (board)
  - Lance Uggla → Mastercard (board)
  - [v] Ajay Banga → Mastercard (già esistente)

  STAKE_IN:
  - Vanguard → Mastercard (8.7%)
  - BlackRock → Mastercard (6.8%)
  - State Street → Mastercard (~4%)

  Pattern rilevanti

  1. Duopolio Visa-Mastercard: ~80% mercato carte globale
  2. Big Three ownership: ~19.5% combinato (pattern comune)
  3. Revolving door FCC→PE→Payments: Genachowski (FCC Chairman → Carlyle → Mastercard board)
  4. Payments CEO → Multilateral: Ajay Banga (Mastercard CEO → World Bank President)
  5. German tech executive: Miebach come Nadella (immigrato, CEO major US company, WEF connected)


"Big Three"
Experian, Equifax, TransUnion : controllano i dati creditizi di miliardi di consumatori globalmente. È un oligopolio de facto: chiunque chieda un mutuo, carta di credito o prestito viene valutato usando i loro dati
[v] charlotte-hogg
[] Mark Begor
[] Mark Feidler
[] Chris Cartwright



PHARMA POWER

  Stato Attuale Database

  | Categoria                     | In Neo4j | Schede Complete | Gap         |
  |-------------------------------|----------|-----------------|-------------|
  | Pharma                        | 26       | 12              | Buono       |
  | Agency (GAVI, WHO, CEPI, FDA) | 4        | 4               | ✅ Completo |
  | Foundation (Gates)            | 1        | 1               | ✅ Completo |
  | Persone pharma                | 26       | 3               | Critico     |
  | Private Equity (Flagship)     | 0        | 0               | Mancante    |

  ---
  Entità da Indagare (Priorità Alta)

  1. PERSONE - Schede Mancanti (Esistono in Neo4j, no .md)

  | ID               | Ruolo                                | Perché Prioritario               |
  |------------------|--------------------------------------|----------------------------------|
  | [v] andre-hoffmann   | Vice-Chair Roche, WEF Co-Chair       | Ponte pharma→WEF→environment     |
  | [v] scott-gottlieb   | Ex-FDA → Pfizer board                | Pattern revolving door chiave    |
  | stephen-hahn     | Ex-FDA → Flagship (Moderna)          | Approva EUA poi va in incubatore |
  | [] albert-bourla    | CEO Pfizer, ex-PhRMA Chair           | Top pharma, WEF                  |
  | thomas-glocer    | Lead Dir Merck + Morgan Stanley, CFR | Ponte pharma→Wall Street→CFR     |
  | noubar-afeyan    | CEO Flagship, Chairman Moderna       | Controlla incubatore + pharma    |
  | [v] margaret-hamburg | Ex-FDA → GAVI, CFR, Gates            | Ponte regolatore→forum→PPP       |

  2. ORGANIZZAZIONI - Mancanti

  | ID                  | Tipo          | Perché Prioritario                        |
  |---------------------|---------------|-------------------------------------------|
  | flagship-pioneering | PrivateEquity | Incubatore Moderna, nexus DARPA-VC-pharma |
  | phrma               | Lobby         | Lobby pharma USA, CEO rotation            |
  | wellcome-trust      | Foundation    | $38B, secondo funder dopo Gates           |
  | global-fund         | Agency        | PPP $2.5B+ da Gates                       |
  | nih                 | Agency        | Co-owner patent Moderna                   |
  | barda               | Agency        | $955M a Moderna, Operation Warp Speed     |

  3. PERSONE - Non nel DB

  | Nome                  | Ruolo                          | Pattern                |
  |-----------------------|--------------------------------|------------------------|
  | Robert Califf         | FDA Commissioner attuale       | Verily/Alphabet $2.7M  |
  | Andrew von Eschenbach | Ex-FDA 2006-09                 | BioTime, Viamet boards |
  | Tim Buckley           | Ex-CEO Vanguard → Pfizer board | Asset manager→pharma   |
  | Cyrus Taraporevala    | Ex-CEO SSGA → Pfizer board     | Asset manager→pharma   |
  | Strungmann twins      | Control ~50% BioNTech          | Dinasty pharma tedesca |
  | Seth Berkley          | Ex-CEO GAVI, COVAX founder     | PPP network            |

  ---
  Pattern da Approfondire

  1. Asset Manager → Pharma Boards

  Vanguard   → Tim Buckley        → Pfizer board
  SSGA       → Cyrus Taraporevala → Pfizer board
  BlackRock  → Larry Fink         → WEF Co-Chair con Hoffmann (Roche)
  Da indagare: Schede Buckley, Taraporevala, approfondimento Big Three ownership in pharma

  2. Defense-Pharma Nexus

  Northrop Grumman (Kathy Warden CEO) → Merck board
  DARPA → Moderna funding ($25M iniziali)
  Da indagare: Scheda Kathy Warden, Northrop Grumman

  3. Swiss Pharma Hub

  Basel = Roche ($68B) + Novartis ($51B) = $120B revenue
  Da indagare: Approfondimento executive rotation tra Roche/Novartis/AZ

  4. mRNA Control

  NIH → co-owner patent → Moderna profitti
  Gates → BioNTech $55M (2019)
  CEPI → BioNTech $145M
  Da indagare: Patent structure, NIH co-ownership dispute

  ---
  Raccomandazione: Prossimi Step

  Priorità 1 - Creare schede persone chiave:
  1. andre-hoffmann - WEF Co-Chair
  2. scott-gottlieb - revolving door emblematico
  3. margaret-hamburg - ponte FDA→GAVI→CFR→Gates

  Priorità 2 - Creare organizzazioni mancanti:
  1. flagship-pioneering - incubatore chiave
  2. phrma - lobby

  Priorità 3 - Completare persone già in DB:
  - stephen-hahn, albert-bourla, thomas-glocer, noubar-afeyan